• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤来源的多能间充质基质细胞的功能特性

Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas.

作者信息

Megnis Kaspars, Mandrika Ilona, Petrovska Ramona, Stukens Janis, Rovite Vita, Balcere Inga, Jansone Laima Sabine, Peculis Raitis, Pirags Valdis, Klovins Janis

机构信息

Latvian Biomedical Research and Study Centre, Ratsupites Street 1 k-1, Riga LV-1067, Latvia.

Clinic of Neurosurgery, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, Riga LV-1002, Latvia.

出版信息

Stem Cells Int. 2016;2016:7103720. doi: 10.1155/2016/7103720. Epub 2016 Jun 2.

DOI:10.1155/2016/7103720
PMID:27340409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4909910/
Abstract

Pituitary adenomas are one of the most common endocrine and intracranial neoplasms. Although they are theoretically monoclonal in origin, several studies have shown that they contain different multipotent cell types that are thought to play an important role in tumor initiation, maintenance, and recurrence after therapy. In the present study, we isolated and characterized cell populations from seven pituitary somatotroph, nonhormonal, and lactotroph adenomas. The obtained cells showed characteristics of multipotent mesenchymal stromal cells as observed by cell morphology, cell surface marker CD90, CD105, CD44, and vimentin expression, as well as differentiation to osteogenic and adipogenic lineages. They are capable of growth and passaging under standard laboratory cell culture conditions and do not manifest any hormonal cell characteristics. Multipotent mesenchymal stromal cells are present in pituitary adenomas regardless of their clinical manifestation and show no considerable expression of somatostatin 1-5 and dopamine 2 receptors. Most likely obtained cells are a part of tissue-supportive cells in pituitary adenoma microenvironment.

摘要

垂体腺瘤是最常见的内分泌和颅内肿瘤之一。尽管从理论上讲它们起源于单克隆,但多项研究表明,它们包含不同的多能细胞类型,这些细胞类型被认为在肿瘤的起始、维持以及治疗后的复发中起重要作用。在本研究中,我们从七个垂体生长激素细胞型、无激素型和催乳素细胞型腺瘤中分离并鉴定了细胞群体。通过细胞形态、细胞表面标志物CD90、CD105、CD44以及波形蛋白表达观察到,所获得的细胞表现出多能间充质基质细胞的特征,并且能够向成骨和成脂谱系分化。它们能够在标准实验室细胞培养条件下生长和传代,并且不表现出任何激素细胞特征。无论临床表现如何,垂体腺瘤中都存在多能间充质基质细胞,并且它们不大量表达生长抑素1-5和多巴胺2受体。最有可能的是,所获得的细胞是垂体腺瘤微环境中组织支持细胞的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/5c115a6f0cf5/SCI2016-7103720.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/056dc243053f/SCI2016-7103720.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/e36578daa6a1/SCI2016-7103720.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/6501770814d3/SCI2016-7103720.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/10f86bbda2f9/SCI2016-7103720.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/d584ad1695d4/SCI2016-7103720.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/12d2b3235297/SCI2016-7103720.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/5c115a6f0cf5/SCI2016-7103720.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/056dc243053f/SCI2016-7103720.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/e36578daa6a1/SCI2016-7103720.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/6501770814d3/SCI2016-7103720.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/10f86bbda2f9/SCI2016-7103720.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/d584ad1695d4/SCI2016-7103720.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/12d2b3235297/SCI2016-7103720.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659e/4909910/5c115a6f0cf5/SCI2016-7103720.008.jpg

相似文献

1
Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas.垂体腺瘤来源的多能间充质基质细胞的功能特性
Stem Cells Int. 2016;2016:7103720. doi: 10.1155/2016/7103720. Epub 2016 Jun 2.
2
Isolation and characterization of human mesenchymal stem cells from gingival connective tissue.从牙龈结缔组织中分离和鉴定人间充质干细胞。
J Periodontal Res. 2015 Aug;50(4):461-7. doi: 10.1111/jre.12228. Epub 2014 Sep 17.
3
Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.生长抑素与多巴胺D2受体共表达在垂体腺瘤中的相关性
Mol Cell Endocrinol. 2008 May 14;286(1-2):206-13. doi: 10.1016/j.mce.2007.12.008. Epub 2007 Dec 23.
4
Assessment of presence and characteristics of multipotent stromal cells in human endometrium and decidua.评估人子宫内膜和蜕膜中多能基质细胞的存在和特征。
Reprod Biomed Online. 2010 Mar;20(3):305-13. doi: 10.1016/j.rbmo.2009.12.011. Epub 2009 Dec 16.
5
Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification.250例垂体腺瘤在世界卫生组织新分类下的临床病理分析
Oncol Lett. 2020 Mar;19(3):1890-1898. doi: 10.3892/ol.2020.11263. Epub 2020 Jan 8.
6
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.Pit-1免疫染色在鉴别原始分化型垂体腺瘤与无功能细胞腺瘤中的应用
Endocr Pathol. 2017 Dec;28(4):287-292. doi: 10.1007/s12022-017-9503-6.
7
Isolation and biological characteristics of multipotent mesenchymal stromal cells derived from chick embryo intestine.
Br Poult Sci. 2018 Oct;59(5):521-530. doi: 10.1080/00071668.2018.1490495. Epub 2018 Sep 17.
8
Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.长效生长抑素类似物联合培维索孟治疗的生长激素分泌型垂体腺瘤中生长抑素受体的表达
Neuroendocrinology. 2017;105(1):44-53. doi: 10.1159/000448429. Epub 2016 Jul 25.
9
Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.功能性生长激素促分泌素受体在人垂体腺瘤中的表达:聚合酶链反应、三重原位杂交及细胞培养研究
J Neuroendocrinol. 1999 Jul;11(7):491-502. doi: 10.1046/j.1365-2826.1999.00351.x.
10
Enhanced cytocompatibility and osteoinductive properties of sol-gel-derived silica/zirconium dioxide coatings by metformin functionalization.通过二甲双胍功能化提高溶胶-凝胶法制备的二氧化硅/二氧化锆涂层的细胞相容性和骨诱导性能。
J Biomater Appl. 2017 Nov;32(5):570-586. doi: 10.1177/0885328217738006.

引用本文的文献

1
Tumor-associated mesenchymal stem/stromal cells in tumor microenvironment and carcinogenesis.肿瘤微环境中的肿瘤相关间充质干细胞与肿瘤发生
Exp Hematol Oncol. 2025 Jul 17;14(1):97. doi: 10.1186/s40164-025-00688-7.
2
Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.垂体神经内分泌肿瘤中的氧化应激:影响肿瘤微环境并成为垂体神经内分泌肿瘤治疗的新靶点。
CNS Neurosci Ther. 2023 Oct;29(10):2744-2759. doi: 10.1111/cns.14315. Epub 2023 Jun 21.
3
Double Pituitary Adenomas in Patients With Cushing's Disease.

本文引用的文献

1
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors.侵袭性垂体肿瘤或局限性垂体癌:垂体肿瘤的定义
Expert Rev Endocrinol Metab. 2016 Mar;11(2):149-162. doi: 10.1586/17446651.2016.1153422.
2
The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.冰岛 1955-2012 年垂体腺瘤的流行病学:一项全国基于人群的研究。
Eur J Endocrinol. 2015 Nov;173(5):655-64. doi: 10.1530/EJE-15-0189.
3
Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
库欣病患者中的双垂体腺瘤
Cureus. 2023 May 12;15(5):e38923. doi: 10.7759/cureus.38923. eCollection 2023 May.
4
The Pituitary Tumors and Their Tumor-Specific Microenvironment.垂体肿瘤及其肿瘤特异性微环境。
Adv Exp Med Biol. 2020;1296:117-135. doi: 10.1007/978-3-030-59038-3_7.
5
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.垂体小体含有特征性的垂体腺瘤肿瘤组织的遗传变异。
Front Endocrinol (Lausanne). 2020 May 22;11:313. doi: 10.3389/fendo.2020.00313. eCollection 2020.
6
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.垂体腺瘤干细胞的实验证据和临床意义。
Front Endocrinol (Lausanne). 2020 Feb 20;11:54. doi: 10.3389/fendo.2020.00054. eCollection 2020.
7
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.垂体肿瘤的微环境——生物学及治疗意义
Cancers (Basel). 2019 Oct 21;11(10):1605. doi: 10.3390/cancers11101605.
8
Pituitary adenomas, stem cells, and cancer stem cells: what's new?垂体腺瘤、干细胞和癌症干细胞:有何新进展?
J Endocrinol Invest. 2018 Jul;41(7):745-753. doi: 10.1007/s40618-017-0803-y. Epub 2017 Dec 8.
9
Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.垂体器官稳态与肿瘤发生中的干细胞/祖细胞
J Endocrinol. 2018 Jan;236(1):R1-R13. doi: 10.1530/JOE-17-0258. Epub 2017 Aug 30.
10
Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways.上皮-间质转化事件和信号通路对垂体干细胞的调控
Mol Cell Endocrinol. 2017 Apr 15;445:14-26. doi: 10.1016/j.mce.2016.09.016. Epub 2016 Sep 17.
垂体瘤包含具有肿瘤干细胞相关特征的侧群细胞。
Endocr Relat Cancer. 2015 Aug;22(4):481-504. doi: 10.1530/ERC-14-0546. Epub 2015 Apr 28.
4
Cancer-associated mesenchymal stem cells aggravate tumor progression.癌相关间充质干细胞加剧肿瘤进展。
Front Cell Dev Biol. 2015 Apr 1;3:23. doi: 10.3389/fcell.2015.00023. eCollection 2015.
5
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.人垂体肿瘤中祖细胞间质细胞的分离和鉴定。
Cancer Gene Ther. 2015 Jan;22(1):9-16. doi: 10.1038/cgt.2014.63. Epub 2014 Dec 19.
7
The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.2001-2011 年期间瑞典西部垂体腺瘤的发病率。
Eur J Endocrinol. 2014 Oct;171(4):519-26. doi: 10.1530/EJE-14-0144. Epub 2014 Aug 1.
8
Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.人脑垂体良性腺瘤中具有低增殖能力的肿瘤干细胞样细胞的证据。
Cancer Lett. 2014 Jul 10;349(1):61-6. doi: 10.1016/j.canlet.2014.03.031. Epub 2014 Apr 13.
9
Silent (clinically nonfunctioning) pituitary adenomas.无功能性垂体腺瘤(临床无功能)
J Neurooncol. 2014 May;117(3):429-36. doi: 10.1007/s11060-014-1425-2. Epub 2014 Mar 28.
10
Pituitary adenomas: an overview.垂体腺瘤:概述。
Am Fam Physician. 2013 Sep 1;88(5):319-27.